Sperm Bank Market Size, Share, Opportunities, And Trends By Donor Type (Known Donor, Anonymous Donor), By Service (Sperm Storage, Semen Analysis, Genetic Consultation), By Fertilization Techniques (Donor Insemination, In Vitro Insemination), And By Geography - Forecasts From 2023 To 2028

  • Published : Aug 2023
  • Report Code : KSI061616026
  • Pages : 142
excel pdf power-point

The sperm bank market is expected to grow at a CAGR of 3.14% to reach a market size of US$5.681 billion by 2028.

The term "sperm bank," "semen bank," or "cryobank" refers to a place or business that acquires, stores, and sells human sperm. Semen is produced and sold by individuals who are well-known sperm donors. A sperm bank is a standalone business that sells donor sperm to people, fertility clinics, or other businesses, or it is a facility maintained by a clinic or other medical institution primarily or solely for its patients or clients.

Sperm bank market growth prospects

The rapid increase in male and female infertility and the government's push to support sperm banks are two major factors that are anticipated to fuel the growth of the sperm bank industry in the projected period. The widespread use of sperm banks around the world, technological advancements, and sperm bank expansion are just a few of the additional reasons that are projected to further fuel the sperm bank market growth. On the other hand, rising medical costs and an antiquated, unfavourable public perception of the sperm bank sector are a couple of the other issues preventing the sperm bank market from expanding.

Increasing infertility cases

As male and female fertility rates rise, the worldwide sperm bank industry is anticipated to expand. Male infertility can also result from using illegal drugs, being exposed to hazardous chemicals, drinking a lot of alcohol, smoking, and other factors aside from inherited diseases. It is a major contributor to poor sperm counts in males and infertility in women. Because of this, the use of infertility services like donor insemination and IVF procedures is increasing the prevalence of male and female infertility globally and fostering the sperm bank market growth.

Rising prevalence of obesity

A risk factor for low sperm counts in men and infertility or poor pregnancy rates in women is the increased incidence of obesity. For instance, the World Obesity Federation presented figures for 2022 that show that in Mexico in 2020, 40.2% of women and 31.5% of men had obesity. In a similar vein, figures reported by Code Blue.org in November 2021 show that the prevalence of overweight and obesity among Malaysian adults grew from 50.1% in 2019 to 54.2% in 2020, which is upsurging the sperm bank market growth.

Growth in government initiatives

Favourable government measures regarding reproductive aid services, such as IVF, artificial insemination & surrogacy, as well as the increase in access & adoption of infertility treatments employing donor sperm, are also anticipated to propel the sperm bank market expansion. For instance, The Andrews Labour Government opened Australia's first-ever public egg and sperm bank in July 2023, increasing access to donor sperm and eggs. The bank at the Royal Women's Hospital, which was opened by Premier Daniel Andrews and Acting Minister for Health Gabrielle Williams, accepts egg and sperm donations from the Victorian community. The egg and sperm bank has cutting-edge lab equipment and fertility experts on staff.

Increasing demand for semen analysis

Throughout the forecast period, semen analysis is anticipated to experience significant growth due to factors such as rising male infertility caused by a variety of conditions, including changing lifestyles, underlying illnesses, and others, rising government initiatives, and rising corporate activities. The need for semen analysis is anticipated to rise as a result of the company's increased focus on creating and releasing testing kits for analysing sperm quality, which is predicted to accelerate sperm bank market growth. For instance, Inherent Biosciences unveiled SpermQT, the epigenetic sperm quality test from Path Fertility, at the American Society for Reproductive Medicine Scientific Congress & Expo in October 2021. DNA methylation patterns on genes related to sperm maturation, sperm production, and embryonic development are examined by SpermQT.

Consumer preference for donor insemination

Donor insemination has a sizable market share since it is inexpensive and easy to do, which is a key factor in the sperm bank industry expansion. Before IVF, it is advised that patients try at least three rounds of artificial insemination because it is less expensive. However, the growing understanding of the benefits of IVF procedures over insemination methods is one of the main factors fueling the expansion of the sperm bank market. One of the main elements fueling expansion is the procedure's high cost. Other reasons influencing the need for IVF include rising male infertility rates and advanced maternal ages in countries like Japan.

The North American sperm bank market is anticipated to grow

North America is anticipated to control the majority of the global sperm bank market due to the rising occurrences of infertility among the American population. Additionally, the availability of advanced assisted reproductive technologies, rising disposable income and healthcare spending, rising public awareness, and the high rate of miscarriages will all contribute to the region's sperm bank market growth throughout the forecast period. Asia Pacific is predicted to have considerable development in the sperm bank market because of the rising occurrence of infertility and miscarriages in the region. Additionally, the quality, quantity, and motility of sperm have decreased due to the rising levels of air pollution in China, which is expected to contribute to the increase.

Europe is predicted to be the new emerging market

The presence of major market players, including Cryos International and others, as well as the wide availability of donor profiles with basic or expanded information are important drivers boosting sperm bank market revenue growth in the European region. Additionally, businesses in the sperm bank industry are continually improving their offerings, expanding their accessibility, and defending the interests of donors and clients by elucidating their problems and assisting them in making better decisions. Significant expenditures in product innovation and research activities have also contributed to the rise of the market's revenue in Europe.

Market Key Developments

  • In July 2023, Australia created its first free public egg and sperm bank in Victoria. The programme is a component of a $120 million project that also consists of free public fertility services including IVF operations, diagnostic exams, and counselling.
  • In June 2022, Perwyn, a pan-European growth-oriented private equity investor, stated that plans to acquire the European Sperm Bank, a Danish company with its headquarters in Copenhagen.
  • In March 2022, Ro, purchased Dadi, a fertility business that facilitates sperm testing, analysis, and storage. Dadi's exclusive collecting, testing, and storage kit was used by Ro to develop Ro Sperm Kit, an improved and renamed product.

Sperm Bank Market Scope:

 

Report Metric Details
Market Size Value in 2028 US$5.681 billion
Growth Rate CAGR of 3.14% from 2021 to 2028
Base Year 2021
Forecast Period 2023 – 2028
Forecast Unit (Value) USD Billion
Segments Covered Donor Type, Service, Fertilization Techniques, and Geography
Regions Covered North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered Xytex, Fairfax Cryobank, California Cryobank, Cryos International, Seattle Sperm Bank, Johns Hopkins Medicine, Apollo Fertility, Indira IVF, Birla Fertility and IVF
Customization Scope Free report customization with purchase

 

Segmentation:

  • By Donor Type
    • Known Donor
    • Anonymous Donor
  • By Service
    • Sperm Storage
    • Semen Analysis
    • Genetic Consultation
  • By Fertilization Techniques
    • Donor Insemination
    • In Vitro Insemination
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Others
 

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. SPERM BANK MARKET, BY DONOR TYPE

5.1. Introduction

5.2. Known Donor

5.3. Anonymous Donor

6. SPERM BANK MARKET, BY SERVICE

6.1. Introduction

6.2. Sperm Storage

6.3. Semen Analysis

6.4. Genetic Consultation

7. SPERM BANK MARKET, BY FERTILIZATION TECHNIQUES

7.1. Introduction

7.2. Donor Insemination

7.3. In Vitro Insemination

8. SPERM BANK MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

10.1. Xytex

10.2. Fairfax Cryobank

10.3. California Cryobank

10.4. Cryos International

10.5. Seattle Sperm Bank

10.6. Johns Hopkins Medicine

10.7. Apollo Fertility

10.8. Indira IVF

10.9. Birla Fertility and IVF

Xytex

Fairfax Cryobank

California Cryobank

Cryos International

Seattle Sperm Bank

Johns Hopkins Medicine

Apollo Fertility

Indira IVF

Birla Fertility and IVF